Shares of Aurobindo Pharma Ltd ended at ₹1,530.60, down by ₹6.70, or 0.44%, on the BSE. Previous Post Orient Technologies wins ₹76 crore NPCI server supply contract with 7-year warranty support Next Post NBCC bags ₹109 crore work orders for Odisha hostels and Srinagar laboratory project Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
